Intracompartmental pressure during hyperthermic isolated limb perfusion for melanoma and sarcoma.
Side effects of isolated limb perfusion (ILP) include rhabdomyolysis, paresthesia, or nerve palsy. The increase in intracompartmental pressure during ILP is thought to be linked to neuro- and muscular toxicity, and fasciotomy is recommended for protection. In 24 patients, intracompartmental pressure was measured. A flexible 5 F probe was placed into the non-tumour-bearing compartment of the perfused limb. Interstitial fluid pressure was measured using a piezoresistant tip. Compartmental pressure values were continuously recorded during and after ILP. The drugs used were a combination of doxorubicin, cisplatinum and melphalan or rhTNF-alpha combined with melphalan. The median overall compartmental pressure prior to ILP was 13 mmHg (range: 11-21 mmHg); during the heat-up phase the median pressure rose to 28 mmHg. During therapeutic perfusion a further increase could be documented and the maximum pressure measured was 90 mmHg; the median of the pressure maxima of all patients was 34 mmHg. During wash-out, at the end of the perfusion, a clear reduction in compartment pressures could be observed and the median dropped to a value of 27 mmHg. In all patients a continuous decrease in compartmental pressure could be recorded, reaching the pre-ILP values by 48 h post-operatively. A dramatic increase in compartmental pressure during ILP can be observed by continuous monitoring. Because of our observation that during the wash-out phase elevated compartmental pressures return to normal, there is no general indication for a fasciotomy. However, for patients maintaining a peak compartmental pressure above a critical threshold of 35 to 40 mmHg fasciotomy may be indicated.
Hohenberger
P
P
Division of Surgery, Robert-Rössle Hospital, Germany.
Finke
L H
LH
Schlag
P M
PM
D001794:Blood Pressure; D001795:Blood Pressure Determination / Q000295:instrumentation; D003161:Compartment Syndromes / Q000209:etiology / Q000503:physiopathology*; D005121:Extremities; D000071938:Fasciotomy; D006801:Humans; D006979:Hyperthermia, Induced; D008545:Melanoma / Q000503:physiopathology / Q000628:therapy*; D008991:Monitoring, Physiologic; D010477:Perfusion / Q000009:adverse effects* / Q000379:methods; D012509:Sarcoma / Q000503:physiopathology / Q000628:therapy*; D013997:Time Factors